JAMA Network

・

頻道・共 21 個節目

醫學

醫學

每週更新
醫學

醫學

隔週更新
醫學

醫學

5 天前更新
醫學

醫學

隔月更新
醫學

醫學

隔月更新
醫學

醫學

隔月更新
醫學

醫學

每月更新

5 天前

Obesity-Related Cancer

Overweight and obesity may cause 10% of new cancer diagnoses annually in the US. In this JAMA Review in the Translational Science series, author Neil Iyengar, MD, of Emory University discusses the biological pathways that may promote cancer in people with overweight or obesity and potential therapies with JAMA Deputy Editor Mary McDermott, MD. Related Content: Obesity and Cancer

5 天前

・

21 分鐘
3月2日

Diagnosis and Treatment of Chronic, Noninfectious Diarrhea

Chronic noninfectious diarrhea affects approximately 6% to 7% of adults in the US and significantly impairs quality of life. Author William Chey, MD, of the University of Michigan joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss strategies for diagnosis and treatment of chronic, noninfectious diarrhea. Related Content: Chronic, Noninfectious Diarrhea

3月2日

・

20 分鐘
3月6日

AI Tools for Patients Have Arrived

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?" Related Content: Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?

3月6日

・

6 分鐘
2月23日

Does This Patient Have Volume Overload? The Rational Clinical Examination

Accurate assessment of intravascular volume facilitates decisions about fluid management in patients with volume overload. Author Edmund A. Liles Jr, MD, of the University of Utah joins JAMA Associate Editor David Simel, MD, MHS, to discuss best evidence from physical exam findings including ultrasound, radiographs, and lab studies for determining volume overload in spontaneously breathing patients. Related Content: Does This Patient Have Volume Overload?

2月23日

・

19 分鐘
1 天前

PrEP Prevents HIV—If Patients Can Get It

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "After a Decade of Progress Against HIV, PrEP Enters a Precarious Era." Related Content: After a Decade of Progress Against HIV, PrEP Enters a Precarious Era

1 天前

・

6 分鐘
2月16日

Type 1 Diabetes: Diagnosis and Management

Type 1 diabetes affects approximately 2 million people in the US and 8.4 million people worldwide. Author Desmond Schatz, MD, of the University of Florida joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of type 1 diabetes. Related Content: Type 1 Diabetes

2月16日

・

17 分鐘
5 天前

Wait Time Modifications for Black Kidney Transplant Candidates

Interview with Rohan Khazanchi, MD, MPH, author of Wait Time Modifications for Black Transplant Candidates Affected by Race-Based Kidney Function Estimation and L. Ebony Boulware, MD, MPH, author of Important Lessons Learned From Eliminating Race-Based Medicine in Kidney Care—Praxis and Policy Matter. Hosted by Eve Rittenberg, MD. Related Content: Wait Time Modifications for Black Transplant Candidates Affected by Race-Based Kidney Function Estimation Important Lessons Learned From Eliminating Race-Based Medicine in Kidney Care—Praxis and Policy Matter

5 天前

・

16 分鐘
1月26日

IgA Nephropathy in Adults

IgA nephropathy is a chronic kidney disease involving deposition of IgA-containing immune complexes in the glomerulus, which often causes kidney failure within 10 to 20 years. Author Michelle Marie O'Shaughnessy, MB, BCh, BAO, MS, of Galway University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the symptoms, risk factors, diagnosis, treatment, and prognosis of IgA nephropathy in adults. Related Content: IgA Nephropathy in Adults

1月26日

・

27 分鐘
5 天前

Epstein-Barr Virus Antibodies and Multiple Sclerosis

Interview with Hannes Vietzen, PhD, author of Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. Hosted by Cynthia E. Armand, MD. Related Content: Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases

5 天前

・

15 分鐘
2025/12/17

WHO Guideline on the Use and Indications of GLP-1 Therapies for the Treatment of Obesity in Adults

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the treatment of #obesity in adults. Francesca Celletti, MD, PhD, and Ezekiel Emanuel, MD, PhD, join JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss. Related Content: World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults

2025/12/17

・

34 分鐘

JAMA Network™ is a collection of 13 medical journals spanning specialties and general medicine. JN podcasts include Editor summaries, author interviews, conversations, clinical updates and more.